ArticleJournal of experimental & clinical cancer research : CR2020

Sirt6 promotes tumorigenesis and drug resistance of diffuse large B-cell lymphoma by mediating PI3K/Akt signaling.

Juan Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.